Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a.American Society of Anesthesiologists (ASA) I-II patients. b.Aged between 18â??65 years. c.Female patients undergoing post-chemotherapy unilateral modified radical mastectomy with complete axillary clearance.
Exclusion criteria
Exclusion criteria: a.Patient refusal and patient unable to give valid consent. b.Patient undergoing supraclavicular lymph node dissection. c.Pregnant patients. d.Known hypersensitivity to local anesthetics e.Infection at the site of injection and f.History of chronic analgesic use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Intraoperative fentanyl requirement to reduce autonomic response due to surgical stimulus 2.Postoperative Visual Analog Scale (VAS) pain score.Timepoint: 1.Total fentanyl requirement at the end of surgical procedure. 2.VAS pain score at 30 minutes interval till 2 hours postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Intraoperative vitals. 2.Postoperative analgesic use in the recovery room 3.Incidence of postoperative nausea vomiting (PONV) Timepoint: 1. Mean of intraoperative vitals at the end of surgical procedure. 2. Total analgesic requirement postoperatively during the recovery room stay for 2 hours postoperatively. 4. occurrence of PONV during the recovery room stay for 2 hours postoperatively. | — |
Countries
India
Contacts
MAHAMANA PANDIT MADAN MOHAN MALAVIYA CANCER CENTRE AND HOMI BHABHA CANCER HOSPITAL